Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jared Allman
Pd32-01 Pre-Clinical Rationale for Combination Pi3k and Brd4 Inhibition in Advanced Prostate Cancer
Journal of Urology
Urology
Related publications
Pd32-09 Combination Effect of Therapies Targeting the Pi3k-Mtor and Ar Signaling Pathways in Prostate Cancer
Journal of Urology
Urology
Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer
Journal of Urology
Urology
Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Molecular Cancer Therapeutics
Cancer Research
Oncology
Combination Hormonal Therapy: A Reassessment Within Advanced Prostate Cancer
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo
Cellular Physiology and Biochemistry
Physiology
Heterogeneity of Advanced Prostate Cancer: Clinical Implications of Genomics
Trends in Urology & Men's Health
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology